Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Pathologic Complete Response × Dermatologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 6 Breast 6 Sarcoma 1 Dermatologic 1

Conditions

Melanoma 270 Skin Neoplasms 145 Carcinoma, Basal Cell 78 Breast Neoplasms 53 Lymphoma, T-Cell, Cutaneous 50 Keratosis, Actinic 49 Leukemia, Lymphocytic, Chronic, B-Cell 40 Mycosis Fungoides 39 Lymphoma, Non-Hodgkin 39 Precursor Cell Lymphoblastic Leukemia-Lymphoma 38 Sezary Syndrome 37 Lymphoma, Large B-Cell, Diffuse 37 Lymphoma, Follicular 37 Lymphoma, Mantle-Cell 36 Lymphoma, B-Cell, Marginal Zone 36 Carcinoma, Squamous Cell 36 Burkitt Lymphoma 36 Lymphoma, Large-Cell, Immunoblastic 34 Hodgkin Disease 34 Lymphoma 33 Multiple Myeloma 32 Neoplasms 31 Leukemia, Myeloid, Acute 30 Leukemia, Myeloid, Accelerated Phase 28 Myeloproliferative Disorders 27 Lung Neoplasms 27 Leukemia, Myeloid, Chronic-Phase 27 Leukemia, Hairy Cell 26 Sarcoma 25 Primary Myelofibrosis 25

Interventions

Cell-Free Nucleic Acids 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02907827 2020-12-17

DW-MRi

Universitair Ziekenhuis Brussel

Phase NA Unknown

Pathologic Complete Response, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡